Cell Source, Inc. (CLCS)
OTCMKTS: CLCS · Delayed Price · USD
0.311
-0.269 (-46.38%)
Mar 28, 2024, 3:25 PM EDT - Market closed

Cell Source Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013
Net Income
-5.17-6.83-5.5-4.78-2.12-3.08-0.97-2.5-4.06-0.03
Depreciation & Amortization
285,300731,502301,25014,970209,65500000
Share-Based Compensation
0.080.420.790.84-0.020.040.110.140.940
Other Operating Activities
-285,298.05-731,498.96-301,248.07-14,968.65-209,654.870.75-0.640.37-0.010
Operating Cash Flow
-3.14-3.38-2.77-2.59-2-2.29-1.49-2-3.12-0.02
Capital Expenditures
00000000-00
Investing Cash Flow
00000000-00
Dividends Paid
00-877,736-741,981-451,283-240,5590000
Common Stock Issued
00728,3471,795,6771,050,0002,295,127071,4003.010.02
Share Repurchases
00149,389-1,053,696000000
Other Financing Activities
3.273.23298,781-2,107,389.4-598,715.35-2,054,565.341.49-71,398.010.1-
Financing Cash Flow
3.273.232.992.61.652.661.491.993.110.02
Net Cash Flow
0.13-0.150.220.01-0.350.37-0-0.01-0.01-0
Free Cash Flow
-3.14-3.38-2.77-2.59-2-2.29-1.49-2-3.12-0.02
Free Cash Flow Per Share
-0.09-0.10-0.10-0.09-0.07-0.09-0.06-0.08-0.14-0.00
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.